Advance in Disease Modeling and Biomarker of Neurodegenerative Disease

Dear Colleagues,

We are organizing a Special Issue entitled “Advances in Modeling and Biomarkers of Neurodegenerative Diseases” to appear in the MDPI journal Cells. We cordially invite you to contribute an original paper or a review manuscript to this Special Issue. The potential contributions will, obviously, undergo a thorough peer review process. With your contribution, we will be able to compile an up-to-date seminal and comprehensive collection which will also be considered to appear as a SI reprints book. Please find the keywords for this Special Issue and its complementary information.

Ageing is the primary risk factor for most neurodegenerative diseases., e.g., one in ten individuals aged ≥65 years has Alzheimer’s disease (AD), and its prevalence continues to increase with increasing age. Given that the populations of many of the richest countries in the world have life expectancies of over 80 years and that continue to increase, the prevalence of neurodegenerative diseases is also increasing. Since the availability of effective treatments for these diseases is scarce, if any, and since these diseases tend to progress in an irreversible manner and are associated with large socioeconomic and personal costs, the emergent need to uncover predisposition biomarkers in order to develop early interventions to prevent the occurrence of pathologies, or, at least, to slow their development, is obvious. The aim of this Special Issue is to assemble original data and reviews illustrating the plethora of models of neurodegenerative disorders and their potential biomarkers that together typify dichotomic behavioral and neurochemical characteristics of health and disease. We hope that contributions from expert groups will result in a compendium supporting researchers (and drug-developing companies) with a continuous interest in neurodegeneration and its treatment, as well as newcomers to this very important field.

With kind regards,
Dr. Galila Agam
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.